Synthesis of novel inhibitors of the HIV-1 protease: difunctional enols of simple N-protected amino acids

Antiviral properties of simple difunctionalized enols targeted to the HIV-1 protease

The human immunodeficiency virus type 1 (HIV-1) protease catalyses the specific cleavage of the virion structural polyproteins p55gag and p160gag-pol and is, therefore, essential for viral maturation. We have previously reported a series of low molecular weight non-peptidic enol-based compounds that inhibit the HIV-1 protease activity in a competitive fashion (Vaillancourt et al., Bioorg. Med. Chem., 2 (1994) 343-355). Here we demonstrate that VS-215 and VS-261, two of these non-peptidic inhibitors, impair viral polyprotein maturation and exhibit antiviral activity in infected MT4 cells. The ID50 for these two compounds ranged between 24 and 50 microM whereas their TD50 ranged between 60 and 200 microM depending on the cell lines used. The calculated therapeutic index of these two inhibitors both had values of 2.5 even though they were shown to be non cytotoxic at their ID50. Their calculated permeability index ranged between 0.09 and 0.79 suggesting that these enol-based inhibitors efficiently reach the site of protease activity. These results provide new information on the therapeutic potential of this new class of protease inhibitors and emphasize the usefulness of enol chemistry in the development of anti-HIV-1 protease inhibitors.

Characterization of dynamic state inhibitors of HIV-1 protease

The inhibitory behavior of simple N-protected amino acids containing a dysfunctional enol group was analyzed. Pseudo-Hill coefficients below 0.5 were obtained for the enol compounds. The active moiety of the enols described herein is involved in an equilibrium between keto and enol forms. The enol in its E form interacts strongly with the enzyme and we suggest that the Z form is expelled from the active site, as suggested by molecular modeling studies using the docking technique. Also, tetrahedral intermediate mimicry is achieved by the enol form, but not by the corresponding keto form. A pseudo-Hill coefficient of 0.25 has been determined for the Boc-phenylalanine enol, and by multiplying the concentration of inhibitor by its pseudo-Hill coefficient, a Ki of 0.82 microM has been determined for the inhibitory E-enol form. Boc-tyrosine enol generated a Ki of 0.39 microM. The requirements at the P1' position to achieve good inhibition are also described.